DeJana Parker
Overview
Explore the profile of DeJana Parker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
17
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alcohol activates cannabinoid receptor 1 and 2 in a model of pathogen induced pulmonary inflammation
Parker D, Muhkopadyay S, Sivaraman V
Toxicol Lett
. 2024 Sep;
401:24-34.
PMID: 39251147
Alcohol use disorder (AUD) is defined as patterns of alcohol misuse and affects over 30 million people in the US. AUD is a systemic disease with the epidemiology of acute...
2.
Onyenwoke R, Leung T, Huang X, Parker D, Shipman J, Alhadyan S, et al.
Food Chem Toxicol
. 2022 Mar;
163:112923.
PMID: 35318090
It is currently understood that tobacco smoking is a major cause of pulmonary disease due to pulmonary/lung inflammation. However, due to a highly dynamic market place and an abundance of...
3.
Zhang R, Jones M, Parker D, Dornsife R, Wymer N, Onyenwoke R, et al.
PLoS One
. 2021 Aug;
16(8):e0256166.
PMID: 34383849
As electronic cigarette (E-cig) use, also known as "vaping", has rapidly increased in popularity, data regarding potential pathologic effects are recently emerging. Recent associations between vaping and lung pathology have...
4.
Sivaraman V, Parker D, Zhang R, Jones M, Onyenwoke R
Front Physiol
. 2021 May;
12:634839.
PMID: 34040540
Though the current preponderance of evidence indicates the toxicity associated with the smoking of tobacco products through conventional means, less is known about the role of "vaping" in respiratory disease....